Drug Shortage Report for AURO-GABAPENTIN
Report ID | 134499 |
Drug Identification Number | 02321211 |
Brand name | AURO-GABAPENTIN |
Common or Proper name | Gabapentin |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100's |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-02-18 |
Estimated end date | 2021-03-30 |
Actual end date | 2021-03-31 |
Shortage status | Resolved |
Updated date | 2021-04-01 |
Company comments | Replaceable with Auro-Gabapentin 300mg Cap 500 Btl |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-02-22 | English | Compare |
v2 | 2021-02-22 | French | Compare |
v3 | 2021-03-31 | English | Compare |
v4 | 2021-03-31 | French | Compare |
v5 | 2021-04-01 | English | Compare |
Showing 1 to 5 of 5